BiotechTube
Home/Axelia Oncology/Anna Galkin, PhD
AG

Anna Galkin, PhD

Chief Scientific Officer

Axelia Oncology

Therapeutic Areas

OncologyImmunology

Axelia Oncology Pipeline

DrugIndicationPhase
AXA-042Solid Tumors (checkpoint‑insensitive)Phase 1

Leadership Team at Axelia Oncology

AL
Ardian Latifi, PhD
Director, Clinical Operations
View full Axelia Oncology profile